Abstract
Introduction: Cardiac Resynchronization Therapy (CRT) improves hemodynamics, symptoms, and overall mortality in patients with advanced heart failure (HF) and ventricular electrical dyssynchrony (QRS duration >120 msec). Previous studies have shown that mechanical dyssynchrony (MD) may be present in up to 45% of patients with advanced HF and QRS duration <120 ms at rest. We determined whether activity induces MD in patients with QRS duration <120 msec. Methods: A total of 47 consecutive patients with left ventricular ejection fraction (LVEF) ≤ 30%, New York Heart Association (NYHA) class II-IV HF, and a QRS complex 65 msec from peak systolic activation of the septal wall to the lateral wall of the left ventricle. Minnesota living with heart failure questionnaire (MLWHFq), EF and NYHA class were assessed to determine risk factors for exercise induced MD. Results: Of the 47 patients, MD occurred in 11 patients (23%) at rest and 5 patients (13%) at exercise. The mean time to peak systolic velocity in the rest and exercise dyssynchrony groups was 105 ± 32 msec and 124 ± 29 msec respectively, compared with 45 +/- 15 msec in patients not experiencing dyssynchrony. No patients experienced electrical dyssynchrony with activity. EF, NYHA class or MLWHF questionnaire were not predictive. Conclusion: MD with activity is not uncommon in patients with HF and a narrow QRS. MD should consider including patients with exercise induced MD as this population otherwise may go ignored. Additionally, patients with pre-existing electrical dyssynchrony who develop MD with exercise may benefit from optimization of their device settings to meet the potential hemodynamic challenge rendered by increased physical activity and heart rate.
Highlights
Cardiac Resynchronization Therapy (CRT) improves hemodynamics, symptoms, and overall mortality in patients with advanced heart failure (HF) and ventricular electrical dyssynchrony (QRS duration >120 msec)
According to current guidelines CRT should be considered in patients with New York Heart Association (NYHA) class II-IV symptoms, impaired systolic function, and interventricular conduction delay (QRS duration of >120 msec) [3]
At the time of enrollment New York Heart Association classification was determined and patients completed the Minnesota living with heart failure questionnaire (MLWHFq)
Summary
Cardiac Resynchronization Therapy (CRT) improves hemodynamics, symptoms, and overall mortality in patients with advanced heart failure (HF) and ventricular electrical dyssynchrony (QRS duration >120 msec). Heart failure with systolic impairment is currently treated with a combination of medications and implantable devices. One such implantable device is the biventricular pacemaker. Biventricular pacemakers pace both the right and left ventricles simultaneously (as opposed to traditional pacemakers which pace from the right ventricle only) This approach is known as cardiac resynchronization therapy (CRT) [1,2]. According to current guidelines CRT should be considered in patients with New York Heart Association (NYHA) class II-IV symptoms, impaired systolic function (left ventricular ejection fraction 120 msec) [3]. The utility of CRT in this population is less well defined
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Cardiovascular Diseases & Diagnosis
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.